SlimeGate 3/7: The Tort-Tort Scam 2/4: The Benzene Bastards

Part Two of SlimeGate’s Tort-Tort Scam chapter is not only an illustration of tort-tort abuse of scientific process for their personal enrichment, it is also an indictment of how IARC has forsaken academic integrity and knowingly is contributing to the Predatort litigation strategy. A small network of scientists prospering as litigation consultants seems to be controlling IARC according to their tort trial opportunities. This exposé on benzene will provide the backstory for what likely happened with glyphosate. It will reveal the following points:

  • Scientists working with toxic tort law firms are compelling IARC to produce monographs for the purpose of increasing their lucrative opportunities as litigation consultants
  • IARC officials are aware of this and complicit in the process
  • Scientists openly declaring financial benefits from relationships with Predatort law firms are still allowed as full IARC monograph panel members
  • Monograph 112 added glyphosate to the list of substances as a seemingly contrived after-thought. There is little doubt the same process of Predatort persuasion was applied for the glyphosate monograph as with benzene.
  • IARC recently quietly updated several monograph publications to hide or change panel member conflict of interest information
  • This WHO agency has been giving prejudicial preference to its “Good Old Boys” network (notably to the benefit of members of the Collegium Ramazzini) and relies on them to viscerally attack anyone who questions IARC.

*****

Benzene is everywhere in modern Western life. When you fill up your car fuel tank, you inhale fumes containing traces of benzene. It is found off-gassing from petrochemicals in everyday plastics, rubbers and paints. Benzene is present in soaps, pharmaceuticals, cosmetics, clothing and furniture. Some claim it is detectable in electronic cigarettes. But our exposure levels are at such low doses (and getting lower) to the point that our precise detection devices are straining to find significant exposure data.

Benzene has been linked to various forms of cancer, but at what dose and for what period of time? It is estimated there may be up to 238,000 people in the US having contracted cancers potentially from benzene occupational exposure. Outside of direct occupational exposure, the public is not at all at risk from low-level contacts with benzene (and compared to other daily exposures to common carcinogens, such fear-mongering about benzene is ridiculous … thus many activists are doing so).

While it is nonsense to think the public should really be concerned, there are, however, a group of scientists (mostly statisticians and epidemiologists) who believe that any benzene exposure level, no matter how small, will cause cancer. They have made a good career out of lending their credibility to Predatort law firms seeking damages from benzene producers and users. These are the Benzene Bastards.

How to Use a UN Agency for Personal Profit

IARC, the International Agency for Research on Cancer, has produced three monographs declaring benzene a Group 1 carcinogen. This might seem like an excessive use of agency resources unless one considers the benefit IARC serves to US toxic tort litigators. SlimeGate is a series of articles (eventually a book) to show how these Predatorts need new scientific links to cancer exposures, how IARC has become central to their business model and how a group of scientists (tort-torts) in the IARC network have been influencing IARC and regulators on behalf of these Predatort law firms.

IARC’s monographs on benzene have been beneficial as evidence for toxic tort lawsuits. It is interesting to note that many of the law firms involved in this benzene bonanza had transitioned to this field once their asbestos honeypot dried up. The second IARC benzene report, however, failed to sufficiently link the substance to non-Hodgkin Lymphoma (NHL) and some tort-torts felt the hazardous exposure levels were set too high. As the Predatort law firms were lining up large numbers of NHL victims that could be linked to benzene exposure (who hasn’t at one time inhaled fumes from products containing benzene?), a link had to be determined. Solution: IARC needed to go back and produce a further benzene monograph (for the pleasure of the Predatorts) that clearly linked benzene to NHL.

Scientists like Bernard Goldstein, Peter Infante and Martyn T Smith have been lining their pockets as litigation consultants on benzene tort lawsuits for more than a decade. All three of them were involved in the 2009 IARC panel on benzene (Monograph 100F) and all of them have complained about the quality of IARC’s work on this monograph. Infante published a paper in 2010 demanding that IARC reconduct their 2009 benzene monograph (100F). Straif and others from IARC replied that they had confidence in the quality of their work and would not reconsider the research.

There was, in fact, a fourth tort-tort, Melvyn Kopstein, who was also trying to pad his personal pension by getting IARC to go back and re-open IARC’s benzene monograph to enable more lawsuits, but Straif rejected the idea point blank in 2015. Frustrated Kopstein went to the media to tell his story (not aware how much his being a greed-driven tort-tort was disgracing the scientific profession). While the Benzene Bastards agreed and sympathised with Kopstein’s arguments, they (and Straif) were not letting him into their sandbox. I suppose if you are not part of their Ramazzini circle, you could not be allowed to “share the wealth”.

2019-02-24 (2)
In 2015, Kurt Straif was clear: IARC will not reconsider benzene!

In an unsigned post, IARC strongly refuted the doubts raised on their process in the Reuters benzene article. They wanted everyone to go away.

Bending the IARC process

Kopstein was not representing the Predatort industry and he had no ties to IARC so he was easily ignored. But the argument still stood: a tighter benzene monograph would translate into better lawsuit payouts. The law firms left the task of generating a link between NHL and benzene to the three Benzene Bastards (but as cancer victims were being lined up for litigation, time was of the essence). So a year later, in 2016, the issue came up again.

This section is based on recent FOIAed documents that revealed some of the IARC actors’ conversations on the third benzene monograph decision.

Goldstein and Infante were tasked with pressuring the head of the IARC monograph programme, Kurt Straif, to convene a third IARC panel on benzene, stating how this was essential as, without the totality of evidence linking benzene to non-Hodgkin Lymphoma (NHL), it would be “harder for plaintiffs to successfully sue industry”.

harder to sue 1
… and screwing industry for all of those litigation consulting fees is what it’s all about!

Did Goldstein feel that the role of IARC was to produce documents for the purpose of having endless litigation “put industry in a preventative mode”. Call me stupid, but I had always thought that was the role of the regulator to decide and not a group of scientists tied to law firms with a network in Lyon. In any case, the point was made clear to Kurt Straif. As the head of the IARC monograph programme, he needed to call another monograph panel on benzene so the lawsuits could flow in the US and Bernie and Peter could profit as they “extract justice” from industry.

Goldstein’s crass email continues, where he schools Straif on regulatory processes and prevention philosophies:

harder to sue 2
Sorry Bernie, go back to school. Hazard identifications are practically useless for prevention.

I could write a piece just on how wrong Goldstein is on risk and hazard, regulatory processes and prevention (I’ll save that for an SRA debate), but for the point of this article, it is clear how the motivation for a further benzene monograph was to help the Predatort law firms to sue industry on a greater scale. This message was sent to Straif in the tone of “calling in a favour”.

But Kurt Straif was having none of this. He knew the only purpose of an IARC benzene/NHL monograph was for the Predatort’s pleasure. Straif replied, once again as the year before (but more politely), that there was no intention to do a further monograph.

Kurt says No

And besides, even if Kurt wanted to help his fellow Ramazzinis feed from the trough, he couldn’t. The head of the monograph programme had to respect proper internal IARC procedure. The 2014 IARC Advisory Committee Report (chaired by the ever neutral, impartial Chris Portier) did not recommend a further benzene monograph in its priorities for the coming five years, case closed. Given how much Straif has said in public about how much better IARC is than EFSA or the BfR in that they have rules and processes, it would be highly embarrassing for Kurt if he then flouted them to help out some friends in dire economic circumstances.

As IARC had no intention of doing a further monograph on benzene, the head of IARC’s monograph programme, Kurt Straif, needed some “persuasion”. Goldstein and Infante prepared a poster on the links between NHL and benzene that they presented in front of 2000 scientists at the IARC 50th Anniversary conference in 2016 (Goldstein was even so arrogant as to dictate to IARC the timing of his presentation so as to fit his personal schedule). Straif was given the heads up how they were coming to Lyon to lobby hard for a further benzene monograph. Procedures can always change when opportunities are lucrative.

Persistent Bernie

No scientific civil servant with any integrity would let himself be pushed around by self-serving, petty tort-torts hunting for consulting payouts … or maybe not. Maybe Kurt could be persuaded in person!

Five months later, in November 2016, IARC announces a monograph meeting on benzene … again. Ka-ching!

iarc

The third benzene monograph was published last December and it drew the connections to NHL needed to appeal to the Predatort pleasure for their slew of benzene/NHL lawsuits. Mission accomplished.

Maybe that is why Kurt Straif is no longer the head of the IARC monograph programme as of … last December. The only thing unpleasant about this news is that Kate Guyton, the only person in IARC more cavalier with procedure and moral conduct than Straif, is now acting head of the monograph programme. Curiously, as the Monograph group is composed exclusively of women, what does that now mean for the “Good Old Boys” network? Is this merely symbolic virtue signalling or does Elisabete have something in mind?

Why Kurt had to Go

The head of the IARC monograph programme relented to the pressure from the Benzene Bastards and, acting outside of normal agency protocol, rushed through a third monograph with no point or purpose but to help his friends identify more lucrative lawsuit opportunities to lend their expertise.  This is a clear benefit for scientists within the IARC network who have been padding their pensions as tort-torts.

But that is only the first scandal.

The process for IARC’s monograph programme is to provide studies based on the recommendations of the External Advisory Panel (the one Kurt got his friend Chris Portier to chair). There was no recommendation in 2015 for yet another monograph on benzene (I suspect Portier was only just learning about the types of revenue a tort-tort could make). Portier himself was co-chairing the IARC Monograph 100F panel (on benzene) so if there were a need for a further monograph, he most certainly would have seen to it when he produced the priorities report.

I contacted Kurt Straif early autumn to get his response on the procedural oversight of holding a third monograph, but he passed my messages over in silence. I suspect I am like Voldemort (he whose name cannot be spoken) to these ridiculously impervious and unaccountable civil servants. Straif knew what was going on with the tort-tort bonanza and was party to it. The utter hypocrisy here is outrageous.

Worse yet on glyphosate, Straif used his position to further attack other agencies (who conducted proper risk assessments) suggesting even how it was worrying how these agencies were influenced by companies like Monsanto, all along while he knowingly fed the Predatort beast with lies and bad science. Good riddance!

But just when you think IARC could not fall deeper into the pit of disgrace, something else pops up to make even the most optimistic Risk-Monger shake his head.

Being a Tort-Tort is a Conflict of Interest

If you are paid $500 an hour to prepare and present depositions and testify in court as and expert witness for plaintiffs suing organisations for cancers they allegedly got from exposure to certain substances, and then you turn around and go to serve on an IARC panel that will produce a monograph which links that substance to the cancers you are getting paid for, it seems patently obvious you have a conflict of interest. You have, quite often, millions of dollars depending on “things going your way”.

A good example would be Martyn T Smith (who will also factor significantly in Part 3 of this chapter). At the time of the second IARC benzene monograph in 2009, Martyn had a pretty good side business going on.  See a list of depositions below (a majority being benzene related) from his CV from that period and ask yourself whether he had time to do anything else. Depositions usually involve providing research documents and background information (much more if there is a Daubert hearing) and can take months. As Smith’s CV only mentioned two courses on toxicology at the time, perhaps Berkeley didn’t need him around too much.

Smith depositions
At least a cool million tort-torting on benzene depositions alone (Source: Smith’s CV)

With this much personal investment in the litigation process, Martyn T Smith would stand to do even better if IARC were to reinforce its benzene cancer assessment.

It is quite possible many tort-torts have a “righteous predisposition”. Some believe they are serving humanity by helping victims receive settlements. There is a strong anti-industry bias in the epidemiology community so I can assume many tort-torts have found religion and see themselves as “angels” delivering justice. That they profit handsomely is merely “generous alms for the crusaders”.

Here is an example of one time-sheet for the preparation and drafting of a single expert report (filed by Chris Portier to Weitz & Luxenberg from his glyphosate deposition).

2019-02-25 (2)

Multiply this amount by 16 in Smith’s case and you can get an idea of some baseline figures before the tort-tort even shows up in court or at a deposition. Righteous predisposition? Sorry Martyn, I’m looking at these numbers and I see it another way.

2019-02-24 (3)
From the original Lancet Oncology PDF

Smith and Bernie Goldstein had the audacity to participate on the second IARC panel in 2009 at the same time as they were consulting for law firms suing benzene manufactures (at least Infante recognised the conflict and only attended as an observer). More audacious is how Smith admitted he had been taking money from both the defence and the plaintiffs in benzene lawsuits.

How could neither of these tort-torts not recognise that receiving hundreds of thousands of dollars per case to depose and testify that benzene is a carcinogen was considered a conflict of interest in determining whether the substance is, indeed, a carcinogen? Worse, how could IARC have not only accepted these two on the panel, in full disclosure, but even proudly announce it (see Lancet Oncology publication)?

On its own, this flagrant misuse of conflict of interest rules with Goldstein’s and Smith’s involvement demonstrates how loathsome and cavalier the IARC monograph programme and its officials can be regarding rules, methodology and ethical principles (especially when it comes down to helping out with financial opportunities for some of their “Good Old Boys”). Keep in mind this conflict of interest is nothing compared to the moral repugnance of forcing IARC to hold a week-long monograph meeting to improve their consulting opportunities with the law firms they are contractually tied to.

But it gets worse.

Disappearing Conflicts of Interest

Is it correct for a WHO agency like IARC to publish a monograph and then secretly go about changing the document? This was the subject of a Reuters special report which IARC vehemently denied. That denial is understandable as rewriting content in a published monograph would suggest IARC does not respect basic rules of scientific integrity.

What is once again indicative of the lack of scientific integrity at IARC (which has sadly become worse since Elisabete Weiderpass was announced as the new head), IARC discovered (probably only recently) that it was not acceptable to have actively consulting tort-torts serving as full members on IARC panels. So the WHO agency in Lyon quietly edited Martyn T Smith’s conflict of interest declaration out of its Monograph 100F page. In the updated Monograph 100F page on benzene, Martyn is no longer declared as actively consulting for Predatort lawsuits on benzene. But they could not get the Lancet Oncology to bend basic scientific ethical rules and rewrite a science publication.

See the updated  IARC page on the benzene panel participants.

2019-02-24 (4)
Smith’s COI as a consultant was present in the Lancet Oncology but missing in 2018 IARC text “update”

Smith’s conflict of interest seems to have fallen off of the page. Why is this? Perhaps Smith demanded that IARC remove his declaration. Frankly, if you are a highly-paid expert witness testifying for both sides of a lawsuit, this suggests you are slimier than the average tort-tort and I could understand why you would like to hide such despicable behaviour.

RM note: This is indicative of how scandal-hardened these IARC officials have become. Last year I had exposed their post-publication editing of the IARC Advisory Group Priorities Recommendations report to pretend that Christopher Portier had declared his interest as an employee of the Environmental Defense Fund at the panel meeting (when in fact he did not).  I used Wayback Machine to show this (see image below). This time the IARC web team removed any crumbs that could show the page updates and history on web archive sites like Wayback Machine. This is a smart way to hide improper actions but in the website address, the geniuses left the update information with: page upload as 062018.
It’s clear IARC are ethically challenged in quietly editing published documents.
It’s clear they were trying to not get caught.
It’s clear they were not very good at it.
… And IARC loves to boast how transparent they are. Pity.

post updated

In quietly changing their monographs post-publication, IARC is behaving like a guilty party trying to cover up its transgressions. But this WHO agency comes across like the little boy with his hand caught in the cookie jar (and quick to lash out at anyone who notices). When will IARC learn to be responsible, honest and, well, mature?

The Same Predatort Playbook for Glyphosate?

As many would give a big “So what!” about benzene (it’s not in my Cheerios or wine and I don’t work with it), keep in mind how this serves as a backstory for the atrocious disregard for process and scientific integrity that is endemic inside IARC and their network of “Good Old Boys”. Could tort-torts have put the same influence as benzene on IARC in a bid to include glyphosate as soon as possible in a monograph given the Predatort strategy to make glyphosate into the next tobacco or asbestos?

The first point to consider was the skittishness of Kate Guyton’s message to all American members of the glyphosate monograph telling them to not respond to freedom of information requests. This flew in the face of US codes of conduct for academic accountability and made minced meat out of IARC’s pathetic claim of being transparent. What was Guyton trying to hide? They have been hiding information for four years … Kate must be morally exhausted.

Even without a similar tort-tort email chain, the situation with glyphosate screams malpractice and collusion. Glyphosate was never in the original list of substances for Monograph 112. The IARC meetings webpage was only updated three times in 2014, in April, July and October. Meeting 112 was first announced on 16 July 2014 and it was only for “Some Organophosphate Insecticides”. As an aside, it should be noted they sent out a call for experts in the summer with a deadline of two weeks for interested parties to apply. This implies IARC had already selected the “Good Old Boys” they wanted in the room (this agency is simply wretched to the core).

IARC meetings
In July, the meeting was only for organophosphate insecticides. The next update added glyphosate.

The next time the webpage was updated was on 7 October 2014 (less than five months before the meeting). Only then was glyphosate announced as a substance for the panel. Glyphosate is not an organophosphate insecticide and it had absolutely no business being included in this meeting on insecticides (worse, after the call for experts period had closed). Why was glyphosate added so late in the process to a list of unrelated substances? Or should we ask: Which tort-tort scientist(s) was lobbying IARC to slip the herbicide into the group on behalf of Predatorts lining up a lawsuit action plan?

We know that Chris Portier had meetings with Lundy and Lundy in the month prior to the IARC glyphosate panel meeting … allegedly for a contract related to cancers arising from mobile phone use (another tort-tort wet dream). It would, of course, be pure coincidence that a mere ten days after the end of the panel meeting declaring glyphosate  a probable carcinogen (the first such agency to ever conclude that) that a contract was inked up and waiting for Portier to sign. Sure, I’ll buy that.

It should not be overlooked that of the American members of the IARC Monograph 112 panel, a good number of them have since been receiving fees as expert witnesses (“bought and paid for” tort-torts). This includes the chair, Aaron Blair, Christopher Portier, Charles Jameson and Matthew Ross. These canaries certainly won’t sing and share their emails. Of course there is a much greater cabal of tort-torts feeding off of the 9000+ lawsuits on glyphosate but these are just the four arriving in Lyon with pension augmentation on their minds. The sound of people humming around the IARC coffee machine in March 2015 must have been quite a sight.

So while everyone is keeping quiet and IARC refuses to be transparent, the evidence seems to point to a strong likelihood that a similar Predatort influence strategy drove IARC towards including glyphosate in a completely different set of substances and delivering the goods the tort-torts needed to bring back to their law firms. Monsanto gets sued, farmers get screwed. Nothing in the behaviour of IARC or its “Good Old Boy” network of tort-torts would convince me otherwise. The Benzene Bastard backstory is useful to understand how IARC operates (and for whom).

Will anyone answer my questions?

Contrary to what my trolls say, The Risk-Monger is concerned by the many forces threatening trust in science and the scientific method. SlimeGate is a series of case studies on how less than honest lawyers are using scientists to enrich themselves. I also feel IARC has badly lost its way on so many levels and has become a threat to the reputation of science and policy. I would like to contribute to the debate on reforming the agency but they do not communicate with me (on the day Elisabete Weiderpass was announced as director, I was even blocked on the IARC twitter page). So in absence of dialogue, and a further circling of the wagons, can anyone answer some of my questions.

– Why was a third IARC monograph linking benzene to NHL essential to the tort-tort litigation strategy if there were enough studies published (as they had said)?
– Why is IARC the only “go-to source” for Predatorts seeking new cancer causalities?
– As Straif knew of the tort-tort motivation and the number of benzene lawsuits depending on IARC determining a link between NHL and low-level benzene exposure, shouldn’t he have resisted simply out of principle?
– Did Straif’s decision to relent to Goldstein’s and Infante’s pressure for a further monograph go against IARC internal policy (of respecting the external panel’s priorities)?
– All of these actors, including Straif, are members of the Collegium Ramazzini. Did the Collegium, a sort of Rotary Club for activist scientists, provide the setting for their strategy?
– Did IARC secretly change their  monographs when someone noticed their COI “Oopsie”?
– Was there a similar type of pressure put on IARC by Predatorts salivating over the potential litigation fee harvest from suing Monsanto over glyphosate?
– Isn’t it time for the scientific community to start cleaning up this slime?

Why are so few journalists looking at this scandal? Are they too afraid to go against the anti-corporate societal narrative? Are they too lazy or underpaid to do any deep-dive research? A sad testimony is I have had this freely available document for eight months (I have been quite sick for a good part of this time) and I never once feared that some journalist was going to beat me to the “news”. The research journalism profession is dead.

  • Given that IARC is not transparent in releasing documents or discussions related to its monograph production;
  • given that law firms do not disclose their correspondence or payments to their scientific tort-torts or NGOs;
  • given that the media is not interested in reporting on the lamentable behaviour of these Benzene Bastards …

… we can only conclude one point: as despicable as these little research recidivists are, they will continue to operate with impunity and continue to disgrace the reputation of the institution they pretend to represent (… and once again, I’ll probably suffer personally for showing this scandalously unethical behaviour).

But whatever happens, IARC’s depravity never ceases to astonish me. You could just imagine my surprise to have read a rather spirited defence of IARC by none other than … Peter Infante. What a terrible postscript to a terrible story.

Postscript: An Infante Terrible

Peter Infante does not work as a scientist but as a litigation consultant on benzene. He attended the last two IARC benzene monographs as an observer (a position usually reserved for people with conflicts of interest like industry actors or governments who will be affected by the consequences of IARC monograph conclusions). He openly declared his interest: representing Predatorts for benzene lawsuits. That is fine. He is able to invoice a high rate for services delivered to satisfied clients (law firms) who make hundreds of millions from lawsuits based on questionable science and he is surely living a good life for services rendered in this toxic tort strategy. I should be happy for him and his very good fortune.

But when he pretends his consulting fees to Predatorts is science, this sliming needs to be evaluated in a proper light. Worse, when he fabricates personal attacks on credible and established scientists or journalists to protect his little financial honeypot and worse yet, when he then accuses them of being in the pay of his adversaries, Infante has crossed so many boundaries of human decency that the word “hypocrite” is far too kind to describe the abhorrent behaviour of this petty tort-tort.

Infante wrote a scathing article against anyone who would dare question the pronouncements of IARC and the value it provides to scientists like, well, himself.  The title said it all: “IARC Monographs Program and public health under siege by corporate interests”.  Infante reinforced the “Monsanto bought the world” conspiracy theory, even referencing sources and documents from activists in US Right to Know and Corporate Europe Observatory (I wish I were making this up!). It was co-authored by other IARC Good Old Boys, litigation consultants and Ramazzini “keepers of the code” including: James Huff, Ronald Melnick and Harri Vainio, former IARC manager now serving as a toxicologist at the Kuwait University (also the better half of Elisabete Weiderpass, IARC’s new head who seemingly stopped using her hyphenated married name when her star started rising within IARC … Ouch!).

The commentary piece was stunning in its visceral and indignant attacks accusing, for example, distinguished scientists like Robert Tarone of being in the pocket of Monsanto (Tarone wrote a convincing article against the IARC Monograph 112 on glyphosate). Then, Infante took aim at the award-winning Reuters journalist, Kate Kelland, claiming she was a Monsanto mouthpiece. At one point, the commentary rifled off a series of references referring to all of them as funded or influenced by, yes, Monsanto. These apparently derogatory claims were made without any evidence but made to sting and slander anyone who would dare question IARC’s legitimacy. Robert Tarone wrote a measured reply to Infante’s rage, reminding him of some basic rules of scientific integrity.

It is incumbent upon the defenders of IARC to address the highly questionable and selective summary of glyphosate rodent studies forthrightly, rather than to question the motivation of critics of the IARC glyphosate classification and to continue to argue from authority that IARC Monograph procedures are beyond reproach.

I have never seen IARC engage in scientific discussions post-publication (they, rather, assume an “arrogance of infallibility”) and frankly I feel the present cabal in Lyon is incapable of such a basic scientific responsibility.

Infante was, in ice hockey terms, playing the role of IARC’s “enforcer”, ready to beat up and discredit anyone who was a threat. The gloves were off but who was giving the marching orders? It is curious that while Infante gave no proof to his claims on Kate Kelland, about a year after his outburst, it was revealed that an email between a Monsanto manager and the Reuters journalist was sealed in court. Were lawyers suing Monsanto leaking confidential documents to Infante for his article? Was that illegal (I’m sure Peter can find a good lawyer to protect him on that one)?

So how much was this “Infante terrible” profiting from IARC and the Predatorts. Well, according to a well-researched analysis by Nathan Schachtman, Peter Infante’s name has come up as a litigation consultant in at least 141 toxic tort cases, all on the plaintiff’s side. A back-of-the-envelope calculation would suggest Peter Infante has earned at least three million USD as a tort-tort consultant (a week socialising in Lyon as an observer to the benzene panel could easily fill his tort-tort time-sheet to the tune of around $50,000 … not counting possible double or triple billing of different law firms).

Money aside, should Infante be the best choice to question the quality of other scientists? In another article by Nathan Schachtman, it is obvious Peter’s scientific skills were not the finest. In the “Burst” benzene case, Infante “ransacked the catalogue of expert witness errors”.  The judge highlighted how Infante committed 12 basic scientific transgressions from cherry-picking to manipulating data to relying on irrelevant studies. To his defence, Infante claimed he was using IARC methodology … enough said.

So Infante writes an article attacking anyone who threatens his little business empire by accusing them of being in the pocket of … business (of being paid off by an organisation only interested in money). Really now! As any epidemiologist worth his salt would attest, evidence matters. There was no evidence to back up Infante’s charges but this little scoundrel’s own closet was so full of damning skeletons. What a hypocrite!

This stinks!

Benzene has had, and will continue to have, a long rich history for Predatorts looking to link people with cancer to their large representation fees. And where this slime exists, it will attract tort-torts with the moral fibre like Peter Infante, Bernard Goldstein and Martyn T Smith. In enriching themselves, these Benzene Bastards will continue to diminish the credibility of science and the reputation of agencies like IARC, a shambolic organisation quite ready to tarnish itself in the service of its network of Good Old Boys.

As for IARC, the agency is like a stinky room. The moment people enter, they think: “Gosh, there is a smell here”. After a bit of time, it becomes evident the smell is quite strong and unpleasant. At a certain point it overpowers as people then come to the realisation there is no means to clear the air. Looking for the source of the stink, it becomes clear the entire room stinks. … Around 15 months ago, my opinion on IARC was sought by different industry actors in Washington. I advised that the US should stay a member and try to reform the agency from within. I thought the stink could be removed from the room. Weiderpass’ performance since she was chosen to lead IARC has shown that the stink wafting throughout the organisation is permanent. It is now evident the only solution is to leave the room.

 

Image source

18 Comments Add yours

  1. Rob Johnston, MD says:

    This is quite brilliant work RM! If there were any HINT of integrity in IARC/WHO/UN, there would be mass firings/resignations.
    The stench of corruption has lingered around the IARC for years but disillusionment (in my case) and sheer apathy (among most others) has — shamefully — allowed those responsible to flourish and their dishonest “appraisals/reports/monographs” to undermine the scientific process and fatally distort public policy.
    The IARC serves no useful function and dishonours ALL European science; it MUST be disbanded and investigated fully with the aim of prosecuting AT LEAST those identified by RM in his devastating series of exposes.
    RM deserves the grateful thanks ot ALL those who practice medicine or make public health policy. Furthermore, RM deserves a MEDAL for heroic public service!

    Liked by 1 person

    1. RiskMonger says:

      Thanks but I would feel uncomfortable being awarded for showing how awful some people are. I would much rather see a seed breeder or chemist working to help farmers get an award. No, I am pretty sure once again they’ll send some of their goons out after me. I am waiting to welcome what they’ll try next.

      Like

  2. Dear Risk Monger

    According to you I am out to trash industry for my own personal gain and in support of predatory law firms. How would you account for the fact that I have through the years served about equally as an expert for defense firms on the side of industry?

    I am proud of the fact that I call the cases as I see them, using my expertise in an unbiased manner. This same expertise, which includes board certification in hematology and toxicology and publication of well over a hundred peer-reviewed papers on benzene, has led to my election to the National Academy of Medicine for which I have chaired over a dozen committees. I have also co-authored the chapter on toxicology for the Federal Judicial Center’s Reference Manual on Scientific Evidence, etc. My most recently accepted paper points out the merit in the “bad luck” cancer hypothesis – certainly not a proplaintiff position. I also served as a political appointee of Ronald Reagan as EPA Asst Administrator for Research and Development

    You, on the other hand, are very good at name-calling, but seem to have no understanding of the role of science in society, or the importance of facts to scientific decisions. You offer to debate me at the SRA. I would be happy to do so. But first you would need to identify yourself, which I suspect you are too afraid to do

    Bernie Goldstein

    Like

    1. RiskMonger says:

      Thank you for your message Bernie. For your information, I am very transparent on who I am (see the About page – https://risk-monger.com/about-2/ – as well as the Facebook and twitter pages). Thinking I would be afraid to confront someone on science policy issues shows how little you understand me. We did, by the way, meet at an SRA meeting in Arlington in December 2017 but our brief conversation was focused on what you do.
      I also call it the way I see it and your email to Kurt seemed quite clear for all to see: you wanted IARC to make the link to NHL to increase plaintiff success in suing industry. That you try to justify this email about wanting to more easily sue industry by claiming to also work with defendants is indicative of how little you understand how such activities as litigation consulting are destroying the reputation and public trust in science.
      You also claim I have no understanding of the role of science and society. Correction. As I said in my exposé, I do not share your view of the role of science in society. You expressed the view in your email, in keeping with the Ramazzini philosophy, that a small group of scientists have a right to change the direction of society by working with tort law firms to litigate industry until they change their policies (or go out of business). That is like saying you should work with thieves to try to change how the public feels about personal security systems.
      You have gone around the normal regulatory and democratic process and feel you and a small group of your friends have the right to sue the hell out of companies until they go out of business or change their ways to be more amenable to a small clique of Good Old Boys who meet in Italy once a year. That is not an acceptable risk management strategy and the more the public sees such underhanded behaviour, the more despicable they will perceive those wearing white coats. When you add to the mix how scientists are working with the greed and slime of the tort industry, I hope you understand why I do not share your “understanding” of the role of science in society.
      I would gladly debate you at an upcoming SRA (note I live in Brussels and nobody pays my costs) but I am not sure you would want to have your stellar reputation (going back to the Reagan administration) being put on the line by my defence of the reputation of science. What we have done in the past is food for our vanity. What we do today dictates how we’ll be judged tomorrow.

      Like

  3. Robert Wager says:

    Tag, you are it Dr. Goldstein…a debate would be very informative.

    Liked by 1 person

    1. NOT A CHANCE. SRA is a scientific organization. Your reply just shows that you are only interested in slinging mud. .

      Like

      1. RiskMonger says:

        I strongly feel that scientists like you do not have the right to short-cut the democratic risk management process by getting lawyers to change practices through relentless litigation floods. Worse that people like you advocate and impose a hazard-based approach on risk managers. You may call this mud-slinging – I call it: clearing the mud out of the scientific community.

        Like

      2. Brett hooper says:

        Goldstein,you stated above you would be happy to debate him.Don’t be a weasel.You accepted.Be a man

        Like

  4. Mr. Zaruk, You really should get your facts straight and not try to out-Trump Trump with your alternate facts. By providing partial quotes from emails you alter the facts and hide the context. You are nothing more than an ill-informed bully. Why didn’t you quote from Straif’s 6/11/17 email in which he admitted that the exposure section in the benzene monograph was not comprehensive? Here is what Straif stated in his email, “The exposure section of the Monographs, in contrast to the sections on cancer in humans, cancer in experimental animals and mechanisms of carcinogenesis (sections 2, 3 and 4, respectively), does not conclude with an evaluation statement and does not contribute to the overall evaluation of the agent. For this reason, the section on exposure (section 1) is not intended to exhaustively review the existing literature as is done in the other sections, but to describe human exposure situations that are pertinent to the evaluation.” (Emphasis added) Later in the same email Straif wrote, “To facilitate management and contain cost this effort was focussed [his misspelling) on the evaluative sections on cancer in humans, cancer in experimental animals and mechanisms of carcinogenesis, while the sections on exposure were condensed.” (Emphasis added) if you had bothered to read my Commentary you would have learned that my positions were well documented and within my field of expertise, chemical engineering. I referenced 65 sources in establishing that the IARC monograph presented facts from industry sponsored papers that intentionally made it seem that products contain far less benzene than is the case, and that benzene exposures arising from their use are trivial – which is decidedly not the case where proper engineering and administrative controls are not in place. A glaring omission in your positions is the fact that you offer no scientific facts consistent with the peer reviewed literature – and indeed you cite none. It seems that you are hungry for a meaningful debate on the issues at hand. I challenge you to just such a debate about my Commentary. What’s more, I will come alone; you may bring a lifeline of chemical engineers and analytical chemists to help you out. You should be more respectful in your blog and stop twisting the facts to suit your purposes

    Like

    1. RiskMonger says:

      Thank you for your contribution Dr Kopstein and your warm personal comments. A few points.
      – You want me to cite peer reviewed articles on benzene. Note my article is an exposé on how IARC is acting on behalf of unethical scientists enriching themselves as litigation consultants and using IARC as a tool to further the interests of the slimy Predatort industry.
      – I did not actually concentrate on your situation (please don’t be offended) as you were easily ignored by Straif and others given you were not part of their Ramazzini club – I share your frustration over how they excluded you and my section on how their little Ramazzini country club (Chapter 6 of SlimeGate) will get into more details on that.
      – To the best of my knowledge, I did not have access to the 2017 email you cited. My focus was on the pressure the Benzene Bastards were putting on Straif in 2016 when there was clearly no intention for a further monograph. After being lobbied at the IARC 50th anniversary, no doubt Straif was beginning to accept the urgency of a further monograph and how an IARC conclusion would be of great benefit to the Predatort law firms and the tort-tort scientists who serve them.
      – Am I right to assume you were not invited to the IARC 50th anniversary where the real tort-tort lobbying on benzene was done. May I suggest you join the Ramazzini club then? They seem to only respect those in their inner circle.
      – The references I used which you accused me were not respectful were all I had access to from the Reuters article (which did not publish the emails but only said they had seen them). If you would like me to publish all of your correspondence with Straif, I would be more than happy to – while the man talks a good talk, he and IARC are anything but transparent.
      I did not focus on you in this exposé on IARC but since I have you here, I would appreciate understanding your motive to work with such slimeball tort law firms rather than work within the scientific community to further your position. Is it because juries are more scientifically inclined than those publishing in journals? Is it because, like I showed in the La Jolla tobacconisation strategy, that this approach (sue the hell out of industry until they change or go bankrupt) is more efficient at changing public policy than the democratic risk management process? Is it because the money is just too good to ever go back to academic practices?
      We clearly have differences of opinion here on the manner in which scientists should conduct themselves. These are questions over the responsibility and integrity of scientists on which I would gladly engage further with you.

      Like

  5. Melvyn Kopstein says:

    Since you discuss my expert witness work in your blog I would have expected you to be aware that my opinions in benzene litigation are completely unrelated to medical causation. They address, a) the concentration of benzene in toluene, regular mineral spirits, and other petrochemicals commonly utilized in products, b) exposures to airborne benzene arising from their use of products at issue, and c) whether the products of interest were required under the OSHA HCS to report the concentration of benzene in the products and include benzene specific health warnings and instructions for safe use. I assume you do not object to workers being made aware about these factors so they and their employers can implement proper engineering and administrative controls – or consider alternative products. My litigation opinions pertain to the fields of chemical engineering and analytical chemistry. I invite you to read my 2018 article in Oxford Bibliographies to learn more about the importance of analytical chemistry in settling differences about the benzene content of petrochemicals; you will be surprised (perhaps not) to learn that analytical testing results embedded in published ‘benzene articles’ do not undergo the scrutiny of peer review. Often times the results in the articles exceed the capability of the most capable ASTM testing methods; namely, they are below the detection limits of those ASTM tests. Again, read my 2018 Oxford article to learn more. I wrote to Straif in 2015 upon learning that Straif et al relied extensively on the ExxonMobil-funded Williams et al 2008 article in the occupational exposure section of the 2012 Benzene Monograph. The lead author of that article wrote in an expert report prepared for defendants in a lawsuit, “ The key findings from this publication [Williams 2008] with respect to occupational exposures to benzene were also cited in IARC’s (2012) most recent monograph on benzene.” I find it odd that you do not discuss defense expert ‘Predatorts’ (your word) in your blog. The role of industry-funded articles in benzene litigation is discussed in “Doubt is their product.” It is a must read if you are to present accurate and balanced points of view in your blog. You should try to be less biased and more respectful. Please let me know if you do not have my Oxford Bibliographies and new Solutions pieces. One other thing to bear in mind: Straif and Loomis wrote a draft response to my New Solutions Commentary. Predictably, it was gratuitous and misleading. Upon learning that New Solutions would publish my response to their letter, it was withdrawn. IARC found it was much safer to post a similarly inaccurate response on its website. Of course, I was not asked to submit my response. Finally, I have an extensive collection of emails with Straif, Loomis, NCI, NIH, and others. If you contact me I will provide you with the emails I received from Straif on 4/28/2015, 6/11/2015, and 9/23/15. I might even provide with the 10/2/17 email I sent to Loomis. I would like to ask you one question: Why didn’t you contact me to get the facts before making derogatory and untrue statements about me in your blog?

    Like

    1. RiskMonger says:

      Please understand Dr Kopstein that I had only given seven lines to your situation in this exposé because you did not matter to IARC or their Ramazzini insiders club (the point of my blog). I believe you know that because why else would you go to the media with your emails? I agree with you that it was unfair that IARC ignores scientists, but they do that all of the time. That is one reason (on top of lying, corruption, hiding COIs, changing conclusions and attacking other agencies) that they should be shut down. Feeling offended by me rather than IARC in this context is, well, comical!
      Now the more you share with me, the more I am offended by you (on top of the fact that you enrich yourself as a tort-tort)!
      You have a different view on a safe level of exposure than those in industry – that’s fine – it is a scientific discussion. But from that you conclude that industry scientists are wrong (and they should be excluded), that their evidence is worthless, that they are happy to see their colleagues die and that they must be punished in a courtroom (where you pick up part of the fat payout). This is ignorant and offensive.
      I worked for 15 years for the chemical industry and as a family we protected our own. One day, I recall, there was an accident in one of our factories in South America and one of our colleagues had died. I went to my office and I cried. We work together, we bring our families to our workplaces together, we share the same values. And you, some academic, who has likely never understood or worked in a company, quotes some piece of shit like “Doubt is their Product” as proof of how evil all industries are and how intelligent you truly are. And then you work with slimeball law firms to hurt people trying to innovate and bring products that improve consumers’ lives based on your ignorance of how industry works.
      I have worked in the academe for ten years now, and as we both know, nobody there gives a shit about anyone but themselves. I have never signed an ethical code of conduct for any university where I have taught. And from your conduct, and the things you are saying, I can safely assume you have not either.
      If you feel like some vigilante standing up against industry while you clearly demonstrate you are ignorant about basic things going on inside of most companies, then I am very relieved that your peers are ignoring you and I suggest you examine your biases and adopt some humility and decency.

      Like

  6. Melvyn Kopstein says:

    I responded twice to your ill-informed and insulting rants. In doing so, I exposed your inane biases along with your ignorance of basic science. Your views on benzene exposure litigation are ludicrous. “Preditort” – what a joke. David, David … Why have you refused to look at – let alone reference – my unedited communications with Straif? Obviously, your proclivity is to distort the context of communications by presenting partial quotes – just as William Barr did. Why do you intractably refuse to accept basic science? What’s next David; that in your world an apple falls straight up? By the way, why haven’t you accepted my challenge to debate you on the specific issues you raised about me? After all, you agreed to debate Dr. Goldstein didn’t you? I note that in this very blog Brett Hooper implored Dr. Goldstein to “be a man” (not a “weasel”) and debate you. C’mon David, man up, don’t be “weasel.” Feel free to assemble a lifeline of chemical engineers and chemists to help you out. However, don’t try to be Trumpian by demanding a debate format in which your lifeline responds to written questions. According to your Linked in summary, “[you] write a blog under the pseudonym: The Risk-Monger – a sort of Socratic gadfly approach towards people who think they know everything and are willing to say anything to win a campaign.” (Emphasis added) Seriously, you actually have the temerity to compare yourself to Socrates?! It’s appropriate to reprise former Senator Lloyd Bentsen’s rejoinder to Dan Quayle: Mr. Zaruk, You are no Socrates.’ May I suggest replacing ‘Socratic gadfly’ with Trumpian in your Linked in summary? You are a joke. Thanks for a good laugh.

    Like

    1. RiskMonger says:

      I’m not sure Melvyn when you had challenged me to a debate, but I always like to engage with people (although I am not sure what the point would be).
      Through all of your insults and name-calling, you seem to have failed to notice that we do have common interests. Both of us have serious issues with IARC (although our motives differ).
      You have a stack of emails of correspondence with Straif – I am looking for more evidence to show how corrupt that rogue agency has become. I only published snippets of your emails (what came from the Reuters article) because that is all I had and rather than recognising that, you accuse me of not referencing the full documents (which to the best of my knowledge has not been published). I am happy to publish them.
      You are angry you got screwed over by IARC (I would argue by Ramazzini) – I get that. I am one of the few people trying to expose them and if you have done some research on me, you would know what they have been doing to me. By calling me a joke, the last laugh is on you.
      You might want to read the full SlimeGate series (until now) before choosing to engage in a debate with me. https://risk-monger.com/issues/slimegate/ My main focus though is on how tort law firms and regulatory vigilantes used IARC as a tool to use glyphosate as a honeypot. Benzene was just the best benchmark.

      Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s